Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Palethorpe

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Nature|January 5, 2001
Does the Queen speak the Queen's English?J Harrington, S Palethorpe, C I Watson
Journal of Experimental Psychology. Human Perception and Performance|July 7, 2000
Reading aloud begins when the computation of phonology is completeK Rastle, J Harrington, M Coltheart, et al.
The Journal of the Acoustical Society of America|December 1, 1996
Vowel classification in childrenS Palethorpe, R Wales, J E Clark, et al.
Cardiovascular Research|April 2, 2003
Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug developmentW S Redfern, L Carlsson, A S Davis, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Nature|January 5, 2001
Does the Queen speak the Queen's English?J Harrington, S Palethorpe, C I Watson
Journal of Experimental Psychology. Human Perception and Performance|July 7, 2000
Reading aloud begins when the computation of phonology is completeK Rastle, J Harrington, M Coltheart, et al.
The Journal of the Acoustical Society of America|December 1, 1996
Vowel classification in childrenS Palethorpe, R Wales, J E Clark, et al.
Cardiovascular Research|April 2, 2003
Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug developmentW S Redfern, L Carlsson, A S Davis, et al.
Pageof 1